Progyny (NASDAQ:PGNY) Releases Q4 2024 Earnings Guidance

Progyny (NASDAQ:PGNY) updated its fourth quarter 2024 earnings guidance on Tuesday. The company provided earnings per share guidance of 0.310-0.350 for the period, compared to the consensus earnings per share estimate of 0.140. The company issued revenue guidance of $266.2 million-$281.2 million, compared to the consensus revenue estimate of $292.7 million. Progyny also updated its FY 2024 guidance to 1.540-1.570 EPS.

Wall Street Analyst Weigh In

Several research firms recently weighed in on PGNY. JMP Securities downgraded Progyny from an “outperform” rating to a “market perform” rating in a report on Thursday, September 19th. Canaccord Genuity Group lowered their price target on shares of Progyny from $24.00 to $18.00 and set a “hold” rating on the stock in a research report on Friday, September 20th. JPMorgan Chase & Co. decreased their target price on Progyny from $31.00 to $22.00 and set an “overweight” rating for the company in a report on Thursday, September 19th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $25.00 price objective on shares of Progyny in a research note on Tuesday, October 1st. Finally, Jefferies Financial Group cut their price objective on Progyny from $31.00 to $24.00 and set a “buy” rating for the company in a research report on Thursday, September 19th. Seven research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, Progyny currently has a consensus rating of “Hold” and an average target price of $27.73.

Progyny Trading Up 0.7 %

Shares of PGNY traded up $0.12 during trading hours on Tuesday, reaching $17.18. The stock had a trading volume of 1,996,870 shares, compared to its average volume of 1,371,571. The company has a market capitalization of $1.55 billion, a price-to-earnings ratio of 27.27, a P/E/G ratio of 1.57 and a beta of 1.44. The firm has a 50-day simple moving average of $18.01 and a 200 day simple moving average of $23.73. Progyny has a 12 month low of $13.93 and a 12 month high of $42.08.

About Progyny

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.